The present study was designed to investigate the significance and the relationship between nasal carriage of Staphylococcus aureus and staphylococcal skin infections. Thirty-one S. aureus strains, isolated from 12 patients with chronic and recurrent skin infections, one patient with septicemia and one patient with otitis externa were studied. The staphylococcal strains were isolated from the site of infection and from the anterior nares of each patient. The identity of both strains of each pair could be demonstrated by determination of phenotypic properties and by genotyping of the isolates. The phenotypic properties included hemolytic activities, antibiotic resistance data, and the production of enterotoxins. The identity was additionally confirmed by phage-typing, by determination of the size and the number of repeats of the X region of spa gene, by determination of gene polymorphisms of coa gene and by macrorestriction analysis of the chromosomal DNA of the isolates by pulsed-field gel electrophoresis. The present results showed an identity of the S. aureus obtained from anterior nares and from skin infection of each patient indicating the importance of nasal carriage of these bacteria for development of human skin infection. ß
Introduction
A great number of studies were performed to gain insight into the epidemiology of Staphylococcus aureus in both, the community and in hospital in order to develop preventive strategies [3, 8, 17] .
The ecological niche of S. aureus strains are the anterior nares and the nose is regarded as the major site of S. aureus carriage. At least 10% of healthy people persistently carry staphylococci in their anterior nares, and 70% to 90% are transient carriers [35] . These S. aureus carriers are at much increased risk for opportunistic infections as compared with noncarriers. An epidemiological link has been shown between nasal carriage and staphylococcal infections in certain groups of patients. These infections included cases of septicemia in patients undergoing hemodialyses and in patients with intravascular devices, wound infections in patients after surgery and staphylococcal infections in human immunode¢ciency virus-infected patients. The epidemiological relation between S. aureus carriage and these infections has been documented by phenotypic and genotypic methods [2, 14, 17, 32, 34, 36] .
However, little is known about the signi¢cance of nasal carriage of staphylococci in the epidemiology and pathogenesis of staphylococcal skin infections. Furunculosis and folliculitis are common skin infections caused by S. aureus and they can periodically recur for many months. Tulloch [28] reported that staphylococci isolated from skin lesions in patients with chronic staphylococcal skin infections were of the same phage-type as the staphylococci isolated from anterior nares of the patients. Although this was known for more than 40 years, there are no further phenotypic or molecular studies con¢rming this relation.
In the present study we report data on phenotypic and genotypic characteristics of S. aureus isolated from the nose and from skin infections of 12 outpatients indicating the signi¢cance of nasal carriage of S. aureus as risk factor for development of human skin infections.
Materials and methods

Bacterial strains and sources of isolation
A total of 31 S. aureus strains were isolated from 14 patients (12 patients with chronic and recurrent skin infections, one patient with septicemia and one patient with otitis externa). One patient with skin infection was examined twice in a period of 2 years. The staphylococcal strains were isolated from the site of infection and from the anterior nares of each patient. The isolate of the patient with septicemia was cultivated using blood culture bottles (BBL, Becton Dickinson, Heidelberg, Germany). The nasal swabs were taken from both anterior nares and immediately streaked on sheep blood agar plates. After incubation for 24 h at 37³C, colonies suspected as S. aureus were isolated. The following criteria were used to con¢rm the species identi¢cation of the S. aureus isolates: production of catalase, a positive tube coagulase test (Bactident-Coagulase, Merck, Darmstadt, Germany) and a positive reaction with Bactident-Staph (Merck). In addition, clumping factor reactions were performed with rabbit plasma on microscope slides. For biochemical characterisation, a commercial identi¢cation system (ID 32 Staph, Bio-Merieux, Nu « rtingen, Germany) was used as recommended by the manufacturer.
Hemolysin detection
The production of hemolysins by the isolates was determined by the interference of the hemolysins within the L-toxin of a S. aureus reference strain. The reference strain was streaked down the centre of a sheep blood agar plate. The S. aureus isolates were cultivated at an angle of 90³ but not touching to the L-toxin-producing strain. After 24 h incubation at 37³C, the plates were examined for hemolysin production as recommended by Skalka [25] .
Antibiotic susceptibility testing
The antibiotic susceptibility was determined by agar diffusion method as recommended by the National Committee for Clinical Laboratory Standards (Standard M-2 A5/ 1995) with the following discs: ampicillin (A, 10 Wg), oxacillin (O, 1 Wg), chloramphenicol (Cm, 30 Wg), cipro£ox-acin (C, 1 Wg), erythromycin (E, 15 Wg), gentamicin (G, 10 Wg), rifampin (R, 5 Wg), tetracycline (T, 30 Wg), sulfamethoxazole/trimethoprim (B, 23,75/1,25 Wg) (all discs: BBL, Becton Dickinson). The susceptibility tests were performed on Mueller^Hinton agar (BBL) with S. aureus strain ATCC 25923 as a control. [4] . The test was performed by routine test dilutions (1:100). Phages that produced a strong reaction determined the phage-type.
Phage-typing
Determination of staphylococcal enterotoxins
The determination of the staphylococcal enterotoxins A, B, C and D was performed by using a semiquantitative reversed passive latex agglutination toxin detection kit (SET-RPLA, Unipath, Wesel, Germany). After incubation for 24 h at 37³C in Todd^Hewitt-broth (THB, Diagnostics Pasteur, Marnes-la-Coquette, France), the cultures were centrifuged and the supernatant examined as recommended by the manufacturer. Wl aqua dest. Finally 1 Wl DNA preparation was added to each 0.2-ml reaction tube. The DNA of the isolates was prepared with the QIAamp Tissue kit as described by the manufacturer (Qiagen, Hilden, Germany). After cultivation of the isolates for 24 h at 37³C in THB, and centrifugation, the pellet was suspended in 180 Wl TE-bu¡er (10 mM Tris^HCl, 1 mM EDTA (pH 8)) containing 5 Wl lysostaphin (1.8 U Wl 31 ). After 30 min incubation at 37³C, 25 Wl of proteinase K (Qiagen) and 200 Wl of bu¡er AL (containing reagents AL 1 and AL 2) was added. The suspension was incubated for 30 min at 70³C and for 10 min at 95³C, and after a spin for a few seconds an amount of 420 Wl ethanol was added to each sample and placed to a spin column. After centrifugation for 1 min the QIAamp spin columns were placed in a clean collection tube and the samples were washed twice with 500 Wl of bu¡er AW (Qiagen). After the second washing, and a centrifugation for 3 min, the QIAamp spin columns were placed in a clean 2-ml microfuge tube and the DNA was twice eluted with 200 Wl of bu¡er AE. The DNA could be stored at 320³C. The ampli¢cation of the tst, eta and etb genes was carried out with the thermal cycler Techne-Progene (thermoDUX, Wertheim, Germany) with the following ampli¢cation cycles: 1 precycle for 4 min at 94³C, followed by 30 cycles denaturation for 2 min at 94³C, annealing of primers for 2 min at 55³C, primer extension for 1 min at 72³C, and a last cycle for 7 min at 72³C to complete elongation. The presence of PCR products was determined by electrophoresis of 8 Wl of the reaction product in a 1.5% agarose gel, with Tris acetate electrophoresis bu¡er TAE (40 mM Tris^HCl, 1 mM EDTA, 1.14 ml l 31 glacial acetic acid (pH 8) and a 100-bp DNA ladder (Gibco BRL Life Technologies, Eggenstein, Germany) or a 50-bp ladder (Roche, Mannheim, Germany) as molecular marker. For control purpose the TSST-1 reference strain 161/93 and the ETA and ETB reference strain 114/98 were included. Both strains were kindly provided by W. Witte, Robert-KochInstitut, Wernigerode, Germany.
PCR ampli¢cation of the X region of the protein A (spa) gene
The determination of the repeat number of the X region of the protein A (spa) gene was performed according to Frënay et al. [10] using the oligonucleotide primers 5P-CAA GCA CCA AAA GAG GAA-3P and 5P-CAC CAG GTT TAA CGA CAT-3P. The ampli¢cation was carried out using the following programme: 1U4 min precycle at 94³C, 35U1 min at 94³C, 1 min at 60³C, 1 min at 72³C, followed by a ¢nal extension incubation of 72³C for 5 min.
PCR ampli¢cation of coagulase (coa) gene
The determination of the repeat number of the coagulase gene was performed according to van Belkum et al [29] . The DNA was ampli¢ed using the oligonucleotide primers 5P-CGA GAC CAA GAT TCA ACA AG-3P and 5P-AAA GAA AAC CAC TCA CAT CA-3P. (The spa-and coa-speci¢c oligonucleotide primers were kindly synthesised by H. Willems, Institut fu « r Hygiene und Infektionskrankheiten der Tiere, GieMen, Germany). The ampli¢cation was carried out with the following programme: 1U4 min precycle at 94³C, 25U1 min at 94³C, 1 min at 58³C, 1 min at 72³C followed by a ¢nal extension incubation of 72³C for 5 min. The PCR product was subsequently digested with the restriction enzyme AluI (10 U; MBI Fermentas). For this 12.5 Wl of the PCR product, 1.0 Wl enzyme and 1.5 Wl 10Urestriction bu¡er were incubated for 2 h at 37³C. The ampli¢ed and digested products were analysed as mentioned above.
Pulsed-¢eld gel electrophoresis (PFGE)
The preparation and digestion of genomic DNA was performed as described previously [27] . The bacteria were cultivated in 40 ml THB, centrifuged, washed in TE bu¡er (10 mM Tris^HCl, 1 mM EDTA (pH 8,0), resuspended in TE bu¡er (5% transmission at 620 nm), and mixed with the same volume of 1% low-melting and low-gelling InCert agarose (Biozym Diagnostic, Hessisch Oldendorf, Germany). The mixture was solidi¢ed for 10 min on ice in special moulds (100 Wl; Bio-Rad Laboratories, Munich, Germany). The cells were lysed by subsequent incubation of the blocks in 200 Wl lysis bu¡er (6 mM Tris (pH 7,6), 1 M NaCl, 10 mM EDTA (pH 7,6), 0.5% Brij-58 (Sigma, Deisenhofen, Germany), 0.2% sodium deoxycholate (Sigma), 0.5% sodium lauroyl sarcosine (Sigma), 5 mg ml 31 lysozyme (Merck, Darmstadt, Germany), containing 5 U ml 31 lysostaphin (Sigma) for 6 h at 37³C. After overnight treatment with proteinase K (¢nal concentration 0.5 mg ml 31 ; Boehringer, Mannheim, Germany) in lysis bu¡er at 56³C, the agarose blocks were washed twice for 30 min each time in TE bu¡er, incubated with phenylmethylsulfonyl £uoride (¢nal concentration 1.0 mM phenylmethylsulfonyl £uoride (Sigma) in 200 Wl TE bu¡er) twice for 1 h each time at 56³C, and washed in TE bu¡er twice for 30 min each time. The genomic DNA of the isolates was digested with the restriction endonuclease SmaI (Stratagene, Heidelberg, Germany). For this, each agarose block was incubated with 1 Wl SmaI (25 U Wl 31 ) suspended in 20 Wl of 10Uuniversal bu¡er (Stratagene) and 179 Wl twice-distilled water for 5 h at 25³C. Samples were electrophoresed at 14³C through 1% chromosomalgrade agarose (Bio-Rad) in a 13-by-14-by-0.55 cm gel containing 0.5 Wg of ethidium bromide (Sigma) per ml in 0.5UTBE (45 mM Tris, 45 mM borate, 1,0 mM EDTA (pH 8.3), in a CHEF-DR II PFGE cell (Bio-Rad) V DNA/ HindIII fragments at 0.1 to 200 kb (Sigma) and V DNA concatemers at 50 to 1000 kb (Sigma) served as standards. The running conditions were as follows. Switch time ramping for digested agarose blocks was for 0.1 to 11 s for 8 h at 5 V cm 31 and then for 9 to 40 s for 17 h at 6 V cm 31 . According to Tenover et al. [26] , restriction patterns with no fragment di¡erence were recorded as indistinguishable, restriction patterns with two or three fragments di¡erence as closely related, those with four and more di¡erences as not related.
Results
According to cultural and biochemical properties all 31 cultures investigated in the present study could be identi¢ed as S. aureus. The identi¢cation was performed with commercial identi¢cation systems (Bactident-Staph, ID 32 Staph) with conventional tests such as coagulase and clumping factor reaction and by determination of hemolytic properties. The cultures were additionally investigated for their antibiotic resistance, for production of enterotoxins and by phage-typing. These characteristics, summarised in Table 1 , are presented in pairs of strains isolated from one and the same individual. Both strains within the pairs were identical according to their hemolysin production, their antibiotic resistances, the secreted enterotoxins and mostly in their phage-type. It was of interest that the isolates from patients with skin infections generally produced enterotoxin B and belonged to phagegroup II. The S. aureus isolates from patients with septicemia and otitis produced enterotoxin A and enterotoxin A together with enterotoxin D and belonged to phagegroup I and III, respectively. It was further of interest that the two S. aureus isolates from patient L in the year 1998 had the same phenotypic properties as the two S. aureus isolated from this patient 2 years earlier. One additional S. aureus isolated from this patient had no comparable phenotypic pro¢le. For genotypic characterisation the 31 S. aureus strains were additionally subjected to PCR ampli¢cation of the tst, eta, etb, spa and coa gene and by macrorestriction analysis of their chromosomal DNA by PFGE. Ampli¢cation of the gene encoding TSST-1 toxin revealed a positive reaction for the S. aureus isolated from anterior nares and from blood culture of patient M. The remaining strains were negative for tst, all strains were negative for eta and etb. The determination of the X region of spa gene indicated that the strains of each pair possessed an identical size of the amplicon and an equal numbers of repeats (Fig. 1 , Table 2 ). The PCR-ampli¢ed products of the repetitive sequences of the coa gene were characterised by the size of the ampli¢ed product and the number and size of the fragments obtained after digestion of the amplicons with the restriction enzyme AluI. The gene polymorphism of the coa gene appeared to be identical in each pair ( Table 2) . Digestion of the chromosomal DNA of the 31 S. aureus strains with the restriction endonuclease SmaI and separation of the fragments by PFGE revealed identical DNA patterns for both strains of each pair. The DNA fragments of the 31 S. aureus strains appeared with six di¡erent patterns with pattern Ia and closely related pattern Ib occurring in 18 isolates of 9 patients. Comparable to the phenotypic properties the genotypic characteristics of four of the ¢ve S. aureus isolates, isolated from patient L were identical (Figs. 2 and 3) . The genotypic properties of the 31 S. aureus strains are summarised in Table 2 .
Discussion
The present study was designed to investigate the signi¢cance and the relationship between S. aureus nasal carriage and staphylococcal skin infections. For several decades, it has been known that S. aureus nasal carriage of patients predisposes to postoperative wound infections. Autoinfection of surgical wounds by S. aureus has already been documented several years ago [6, 31, 33] . Weinstein [31] presented data that S. aureus was the organism isolated in 94% of the wound infections and that 92% of nasal carriers with postoperative staphylococcal wound infections demonstrated identical S. aureus phage-types from both nose and wound cultures. A direct link between nasal carriage of S. aureus and subsequent infections by the same organism was also demonstrated in a 5-year prospective study of hemodialysis patients [36] . Similarly, in a study carried out by Ena et al. [9] , patients who developed staphylococcal infections while undergoing hemodialysis were found to be infected by strains persistently carried in their nares. An association between nasal carriage of S. aureus and subsequent infections was also described in studies evaluating patients on continuous ambulatory peritoneal dialysis (CAPD) [23] . On the bases of typing methods Coia et al. [7] found identical isolates from the site of infection and from carriage sites. These results showed that for patients on CAPD a S. aureus carriage is an important risk factor for development of S. aureus infections. However, the information available about nasal carriage and the development of S. aureus skin infection is limited. The epidemiology of these infection has not yet been established. In the 1950s, studies of Tulloch [28] indicated that recurrent staphylococcal skin infections may be associated with a nasal carriage of staphylococci. In addition, Gould and Cruickshank [12] presented data that 86% of the patients with staphylococcal skin infections are also nasal carriers of this bacterium. Kay [16] also found that patients with infections of the skin become infected by the staphylococcal strain carried in their nose.
The data shown in the present study demonstrated an epidemiological relation between S. aureus isolated from the anterior nares and from skin infections of the patients. As shown for patient L this nasal carriage appeared to be stable at least for a 2-year period. These ¢ndings correspond to data presented previously [27] . The identity of the S. aureus isolates in each pair could be demonstrated phenotypically by hemolysin production, their antibiotic resistances, the secreted enterotoxins and by phage-typing. Most of the isolates appear to be N-hemolytic. The antibiogram typing of the isolates revealed a predominance of relatively susceptible strains and an identity between nasal isolates and the corresponding strain from the site of infection. The staphylococcal pairs isolated from patients with skin infection and from the patients with septicemia and otitis, respectively, revealed an identity within the pairs according to their enterotoxin production, and mostly in their phage-types. The limitation of phage-typing as a typing method was recognised by numerous authors [7, 13] . Notably, the staphylococcal strains from nasal carriers with the skin infections belonged to the phagegroup II, a typical phage-group for S. aureus isolated from skin lesions [24] , while staphylococcal isolates from patients with septicemia and otitis were of phage-group I and III, respectively. The 31 S. aureus strains were further investigated genotypically. The PCR amplicons of the tst, spa and coa gene were examined electrophoretically and revealed an identity in each staphylococcal pair. None of the strains examined were positive for eta and etb. These results are in contrast with the studies of Roeb et al. [21] , who presented data that S. aureus from phage-group II usually produce exfoliative toxin. The only positive pair for tst gene were the S. aureus isolates obtained from the patient with septicemia. These isolates showed a typical phage-pattern for producers of TSST-1 [20] .
The X region of the spa gene is characterised by a variable number of repeats and although polymorphic, this region is su¤ciently stable to be a suitable target to discriminate between S. aureus strains within short time frame [10] . According to the results of the present study the determination of the X region of the spa gene indicated that the strains of each pair possessed an identical size of the amplicon and an equal number of repeats. In addition, the gene polymorphism of the coa gene has been commonly used for molecular typing of S. aureus [11, 30] . As Fig. 3 . PFGE pattern of the chromosomal DNA of the ¢ve S. aureus isolates, isolated from patient L (see Fig. 2 ) after digestion with endonuclease SmaI; M: V DNA HindIII fragments, 0.1^200 kb, and V concatemers, 50^1000 kb.
described by Goh et al. [11] the discriminatory power relies on the heterogeneity of the region containing the 81-bp DNA tandem repeats which di¡er in both in the number of tandem repeats and the location of AluI restriction sites among various isolates. The ampli¢cation of the coa gene of the isolates in the present study also showed an identity in each pair. The identity of both strains of each pair could additionally be demonstrated by macrorestriction analysis of chromosomal DNA by PFGE. In addition, these analysis further demonstrated that most of the S. aureus-clones of the various patients seemed to be identical or at least closely related. An interhospital, even intercontinental spread of single S. aureus clones has been reported by numerous authors [1, 5, 19, 22] . However, the occurrence of S. aureus with identical DNA-¢ngerprints and di¡erences in phenotypic properties or in size or restriction sites of the spa or coa gene might be caused by evolutionary processes. PFGE is well known in being superior in typeability and reproducibility, and allows an excellent discrimination between strains [18, 27] . The results of the present study clearly documented that S. aureus nasal carriage appears to be a major risk factor and a reservoir for staphylococcal skin infections. It would be further of interest whether an eradication of the nasal carriage might prevent recurrent skin infections.
